Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan Wysocki
Hypertension (Dallas, Tex. : 1979)|May 26, 2026
Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE InhibitorRomy Fischer, Jan Wysocki, Luise Hassler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 15, 2021
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19Luise Hassler, Fabiola Reyes, Matthew A Sparks, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Journal of the American Society of Nephrology : JASN|February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney OrganoidsJan Wysocki, Minghao Ye, Luise Hassler, et al.
Kidney360|January 2, 2026
Transforming the Venous Blood Gas to the Arterial Blood Gas from Concurrent MeasurementsDaniel Batlle, Romy Fischer, Luise Hassler, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Pageof 2